Mirna Pushes Series B, First IND Guidance to 2012
January 20, 2011
Mirna Pushes Series B, First IND Guidance to 2012
Despite the delay, Mirna has gained some traction in its efforts to form an industry partnership, having inked technology-evaluation deals with two pharmaceutical companies.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Closing $1.5M Financing Round, Mirna Still Seeks More Cash and Delays First Phase I to 2013
August 25, 2011 / Gene Silencing News - Mirna Series B Sees Slight Delay as miRNA Rx Field Grows
October 21, 2010 / Gene Silencing News - People in the News: Sinil Kim
June 6, 2013 / Gene Silencing News - Mirna Becomes First to Advance Therapeutic microRNA Mimic into Human Testing
May 2, 2013 / Gene Silencing News - Silence Plans $28.6M Stock Sale to Fund Expansion of Staff, Pipeline
April 11, 2013 / Gene Silencing News